keyboard_arrow_right
Search keyboard_arrow_right
keyboard_arrow_left Hide
Friday, September 25th - ET (Eastern Time, GMT-05:00)
search
Friday, September 25th - ET (Eastern Time, GMT-05:00)
search
Showing 1 of 1 Streams
Networking Break
7:30am - 8:00am
Networking Breakfast
Showing 1 of 1 Streams
General Session
8:00am - 8:10am
Chair's Day One Recap
8:10am - 9:00am
Optimizing ERP Systems: Tools and Strategies for Biotech Growth
- Discover how to apply practical lessons from ERP implementations and transitions to advanced systems as organizations grow
- Explore ways to align ERP tools with company size, operational needs, and cross-departmental IT requirements
- Master the process of selecting and integrating essential software, including equity administration platforms and procurement-to-payment systems
- Uncover strategies to address implementation pain points and optimize post-implementation efficiency and financial reporting accuracy
CPE Credits Available: 1.2
- Kyle Mandala - Life Sciences Enterprise Resource Planning (ERP) Strategy Director, RSM US LLP
- Maggie Berkeley - Biopharma Sector Leader and Risk Advisory Principal, RSM US LLP
- Michelene Taptich - Vice President, Commercial Accounting, Priovant Therapeutics
- Gina Tracey - Vice President, Corporate Controller, Alnylam Pharmaceuticals
9:00am - 9:50am
Biotech Financing Insights: Navigating Dynamic Capital Markets
- Dissect the latest trends in capital markets and implications for biotech funding strategies
- Explore what investors prioritize across pre-commercial, clinical, and commercial stages, and learn how to align organizational goals with these expectations
- Discover strategies to leverage the recent upswing in capital markets to support growth, innovation and long-term success
- Examine non-traditional funding options, such as venture capital, private equity, and strategic partnerships and their role in driving financial sustainability
CPE Credits Available: 1.2
- Adam Mostafa - Chief Financial Officer, Sitryx Therapeutics
- Ethan Holdaway - Vice President, Strategic Finance & IR, ProKidney
9:50am - 10:40am
Portfolio Prioritization & Capital Strategy: Strategic Decision Frameworks for Biotech Finance
- Master portfolio tradeoff frameworks that enable finance leaders to evaluate competing clinical programs and support go/no-go decisions in resource-constrained environments
- Explore non-dilutive capital strategies, including strategic partnerships and licensing arrangements and learn when to pursue partnering versus traditional funding routes
- Develop runway modeling approaches that inform critical decisions about program prioritization, cash preservation and strategic timing in clinical-stage biotech
- Enhance board communication strategies for presenting portfolio tradeoffs, partnering opportunities and capital allocation scenarios to ensure strategic alignment
- Mallory Morales - Senior Vice President Finance, Chief Accounting Officer, Treasurer, Immuneering Corporation
- Laura Vasquez - Head of FP&A & Business Operations, Rocket Pharmaceuticals
Showing 1 of 1 Streams
Networking Break
10:40am - 11:10am
Networking and Refreshment Break
Showing 1 of 1 Streams
General Session
11:10am - 12:10pm
CFO Panel: Redefining Financial Leadership for Organizational Success
- Explore how today's biotech CFOs are reshaping their roles to become catalysts for innovation through driving transformation to elevate finance functions and enable sustainable growth and operational excellence
- Gain valuable perspectives from seasoned CFOs as they share their unique career paths, lessons learned, and actionable advice for emerging finance professionals
- Engage in discussions on overcoming industry challenges, fostering team resilience, and leveraging data-driven strategies to stay ahead in a dynamic business environment
CPE Credits Available: 1.2
- Justin Renz - Chief Financial Officer, Zevra Therapeutics
- Kory Wentworth - Chief Financial Officer, Entrada Therapeutics
Showing 1 of 1 Streams
Networking Break
12:10pm - 1:10pm
Networking Luncheon
Showing 1 of 1 Streams
General Session
1:10pm - 2:10pm
Navigating Clinical Trials Finance: Accruals, Automation and AI Integration
- Delve into the complexities of clinical trial accruals and their critical role in bridging finance for commercial professionals and clinical teams
- Discover how biotech companies are leveraging innovative accounting tools and automated systems to transform budgeting, forecasting, and clinical trial management to reduce risks and improve operational efficiency
- Gain actionable strategies for designing processes that anticipate inaccuracies, ensuring accurate accrual recording while staying audit-ready
CPE Credits Available: 1.2
- Jennifer Kyle - Founder and CEO, Condor Software
2:10pm - 3:10pm
AI in Action: Practical Use Cases Transforming Biotech Finance Operations
This dynamic session will feature three use case presentations from biotech professionals, each highlighting a unique, real-world example and outcome of AI application and adaptation strategies to improve efficiency and productivity in finance and operations.
- Explore how AI is transforming workflows in forecasting, GTN operations, clinical approval, and expense reporting
- Learn how AI adoption impacts financial reporting accuracy and strategies to address compliance concerns, including IP leakage, data security, and audit implications of AI adoption
- Discover how AI enables predictive finance models, driving proactive decision-making and operational agility
CPE Credits Available: 1.2
- Martin Hildebrand - Senior Solutions Consultant, Sage Software
3:10pm - 4:10pm
Mastering Capital Allocation: Strategies for Successful Commercialization and Product Launches
- Explore real-world strategies for balancing capital allocation across R&D, commercialization, and portfolio management
- Learn best practices for managing costs, optimizing resources and scaling operations in today’s funding environment
- Gain practical tools and frameworks to make smarter financial decisions and ensure successful commercialization outcomes
CPE Credits Available: 1.2
- Melissa Bradford-Klug - Chief Financial & Business Officer, NorthSea Therapeutics
- Nikita Mody-Patel - Executive Director, FP&A, Moderna Therapeutics
4:10pm - 4:15pm
Chair's Closing Remarks & Close of Conference
